Results 121 to 130 of about 7,450 (200)
Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids [PDF]
Glucosylceramide synthase (GCS) catalyzes the first committed step in the biosynthesis of glucosylceramide (GlcCer)-related glycosphingolipids (GSLs). Although inhibitors of GCS, PPMP and PDMP have been widely used to elucidate their biological function ...
Alam, Shahidul +3 more
core
Simple Summary Neuroblastoma (NB), a prevalent childhood cancer, presents challenges in treatment due to its cellular diversity and the presence of tumor-derived endothelial cells (TECs) associated with chemoresistance.
Aranzazu Villasante +6 more
semanticscholar +1 more source
Neuropathic pain is a hallmark symptom in Fabry disease (FD), a hereditary X-linked lysosomal storage disorder caused by a reduced activity of α-galactosidase A (α-Gal A).
Francesco Formaggio +10 more
doaj +1 more source
Gas Phase Infrared Spectroscopy of Glycolipids
Carbohydrates and lipids are not only energy sources and structural components of cells but fulfill very diverse and important roles in a multitude of cellular processes. The combination of a carbohydrate and a lipid linked via a glycosidic bond yields a
Kirschbaum, C.
core
Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body [PDF]
core +1 more source
From Shoulder to Heart: Acute Shoulder Pain Leads to a Diagnosis of Fabry Disease. [PDF]
Kalaria A +4 more
europepmc +1 more source
Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]
Gómez-Cebrián N +5 more
europepmc +1 more source
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension. [PDF]
Nordbeck P +21 more
europepmc +1 more source
Case Report: Fabry disease presenting with electrocardiographic findings mimicking acute myocardial infarction: a diagnostic challenge. [PDF]
Xie JM, Li Q, Xiao ZQ, Zheng ZJ.
europepmc +1 more source

